Literature DB >> 9125124

Butyrate stimulates cyclin D and p21 and inhibits cyclin-dependent kinase 2 expression in HT-29 colonic epithelial cells.

S Siavoshian1, H M Blottiere, C Cherbut, J P Galmiche.   

Abstract

Sodium butyrate, a product of colonic fermentation of dietary fiber, has been shown to inhibit cell proliferation by blocking the cells in the G1 phase of the cell cycle. However, its mechanism of action is still unknown. We found that butyrate strongly stimulated cyclin D and p21/WAF1/CIP1 expression in HT-29 human colonic adenocarcinoma cells, in a dose dependent manner. These stimulations were associated with a decrease in cyclin-dependent kinase (cdk) 2 level, whereas cdk4 and cdk6 remained unchanged. Our results suggest that the inhibition of cell cycle progression by sodium butyrate may be explained by a modulation of cell cycle regulatory proteins such as cyclin D and p21.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125124     DOI: 10.1006/bbrc.1997.6255

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Microbial Metabolites as Molecular Mediators of Host-Microbe Symbiosis in Colorectal Cancer.

Authors:  N P Hyland; A Houston; J M Keane; S A Joyce; C G M Gahan
Journal:  Results Probl Cell Differ       Date:  2020

2.  A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors.

Authors:  A Saito; T Yamashita; Y Mariko; Y Nosaka; K Tsuchiya; T Ando; T Suzuki; T Tsuruo; O Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

3.  Histone deacetylases inhibitors effects on Cryptococcus neoformans major virulence phenotypes.

Authors:  Fabiana As Brandão; Lorena S Derengowski; Patrícia Albuquerque; André M Nicola; Ildinete Silva-Pereira; Marcio J Poças-Fonseca
Journal:  Virulence       Date:  2015-06-23       Impact factor: 5.882

4.  The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype.

Authors:  Mònica Comalada; Elvira Bailón; Oscar de Haro; Federico Lara-Villoslada; Jordi Xaus; Antonio Zarzuelo; Julio Gálvez
Journal:  J Cancer Res Clin Oncol       Date:  2006-05-17       Impact factor: 4.553

5.  Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression.

Authors:  S Siavoshian; J P Segain; M Kornprobst; C Bonnet; C Cherbut; J P Galmiche; H M Blottière
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

6.  Short-chain fatty acids induce cytoskeletal and extracellular protein modifications associated with modulation of proliferation on primary culture of rat intestinal smooth muscle cells.

Authors:  G Le Blay; H M Blottière; L Ferrier; E Le Foll; C Bonnet; J P Galmiche; C Cherbut
Journal:  Dig Dis Sci       Date:  2000-08       Impact factor: 3.199

7.  A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program.

Authors:  A Mal; M Sturniolo; R L Schiltz; M K Ghosh; M L Harter
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

8.  Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell line.

Authors:  Jennifer S Waby; Haridasan Chirakkal; ChenWei Yu; Gareth J Griffiths; Roderick S P Benson; Colin D Bingle; Bernard M Corfe
Journal:  Mol Cancer       Date:  2010-10-15       Impact factor: 27.401

9.  Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate.

Authors:  Sabita N Saldanha; Rishabh Kala; Trygve O Tollefsbol
Journal:  Exp Cell Res       Date:  2014-02-08       Impact factor: 3.905

10.  Cell-bound Exopolysaccharide Extract from Indigenous Probiotic Bacteria Induce Apoptosis in HT-29 cell-line.

Authors:  Parisa Mojibi; Farzaneh Tafvizi; Maryam Bikhof Torbati
Journal:  Iran J Pathol       Date:  2018-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.